The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Cancer vaccines
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Self-citationLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
Hoiseth, S. K., & Stocker, B. A. D. (1981) · Nature · doi:10.1038/291238a0 · Cited by 2,078
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
New use of BCG for recombinant vaccines
Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., Hatfull, G. F., et al. (1991) · Nature · doi:10.1038/351456a0 · Cited by 1,490
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M., & Hengartner, H. (1991) · Cell · doi:10.1016/0092-8674(91)90164-t · Cited by 1,173
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Self-citationA p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884
Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Drijfhout, J. W., Schegget, J. T., Melief, C. J. M., & Kast, W. M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230929 · Cited by 825
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Murine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
Hunter, T. (1991) · Cell · doi:10.1016/0092-8674(91)90637-e · Cited by 767
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
Golumbek, P. T., Lazenby, A. J., Levitsky, H. I., Jaffee, L. M., Karasuyama, H., Baker, M., & Pardoll, D. M. (1991) · Science · doi:10.1126/science.1948050 · Cited by 719
Self-citationInduction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., & Levitsky, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 704
Self-citationImmunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997) · Science · doi:10.1126/science.278.5335.117 · Cited by 680
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
Gong, J., Chen, D., Kashiwaba, M., & Kufe, D. (1997) · Nature Medicine · doi:10.1038/nm0597-558 · Cited by 591
Parkhurst, M. R., Salgaller, M. L., Southwood, S., Robbins, P. F., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2539 · Cited by 556
Paglia, P., Chiodoni, C., Rodolfo, M., & Colombo, M. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.317 · Cited by 542
A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells
Adema, G. J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., et al. (1997) · Nature · doi:10.1038/42716 · Cited by 523
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3
Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwuck, R., Humblet, Y., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630622 · Cited by 417
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., & Feldman, M. (1985) · Nature · doi:10.1038/315301a0 · Cited by 402
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., & Allison, J. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8099 · Cited by 394
Huang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 388
Self-citationSong, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A. S., & Crystal, R. G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1247 · Cited by 379
Paracrine Cytokine Adjuvants in Cancer Immunotherapy
Pardoll, D. M. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.399 · Cited by 369
Self-citationUdono, H., Levey, D. L., & Srivastava, P. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3077 · Cited by 347
Wu, T. C., Guarnieri, F. G., Staveley-O'Carroll, K. F., Viscidi, R. P., Levitsky, H. I., Hedrick, L., Cho, K. R., August, J. T., & Pardoll, D. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11671 · Cited by 344
Self-citationRejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
Hui, K., Grosveld, F., & Festenstein, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 341
Kast, W. M., Roux, L., Curren, J., Blom, H. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., & Melief, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2283 · Cited by 326
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Immunotherapy of malignancy by in vivo gene transfer into tumors.
Plautz, G. E., Yang, Z. Y., Wu, B. Y., Gao, X., Huang, L., & Nabel, G. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4645 · Cited by 317
A novel type of human papillomavirus associated with genital neoplasias
Beaudenon, S., Kremsdorf, D., Croissant, O., Jablonska, S., Wain-Hobson, S., & Orth, G. (1986) · Nature · doi:10.1038/321246a0 · Cited by 316
Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines
Aldovini, A., & Young, R. A. (1991) · Nature · doi:10.1038/351479a0 · Cited by 313
Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., & Ohashi, P. S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.645 · Cited by 309
The Interaction of Bacteria with Mammalian Cells
Falkow, S., Isberg, R. R., & Portnoy, D. A. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002001 · Cited by 302
Berd, D., Maguire, H. C., McCue, P., & Mastrangelo, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1858 · Cited by 300
Van den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., & Boon, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Fu, T.-M., Ulmer, J. B., Caulfield, M. J., Deck, R. R., Friedman, A., Wang, S., Liu, X., Donnelly, J. J., Liu, M. A., & Wigzell, H. (1997) · Molecular Medicine · doi:10.1007/bf03401683 · Cited by 296
Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., & Hwu, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1213 · Cited by 294
Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 291
Topalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Live recombinant vaccinia virus protects chimpanzees against hepatitis B
Moss, B., Smith, G. L., Gerin, J. L., & Purcell, R. H. (1984) · Nature · doi:10.1038/311067a0 · Cited by 281
MONTGOMERY, D. L., SHIVER, J. W., LEANDER, K. R., PERRY, H. C., FRIEDMAN, A., MARTINEZ, D., ULMER, J. B., DONNELLY, J. J., & LIU, M. A. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.777 · Cited by 262
Suzue, K., Zhou, X., Eisen, H. N., & Young, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13146 · Cited by 250
Exposing the immunology of naked DNA vaccines
Pardoll, D. M., & Beckerleg, A. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90085-3 · Cited by 249
Self-citationUyttenhove, C., Maryanski, J., & Boon, T. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.3.1040 · Cited by 245
A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier
XIANG, Z. Q., YANG, Y., WILSON, J. M., & ERTL, H. C. J. (1996) · Virology · doi:10.1006/viro.1996.0239 · Cited by 241
Peptide-induced antiviral protection by cytotoxic T cells.
Schulz, M., Zinkernagel, R. M., & Hengartner, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.991 · Cited by 238
Pan, Z.-K., Ikonomidis, G., Lazenby, A., Pardoll, D., & Paterson, Y. (1995) · Nature Medicine · doi:10.1038/nm0595-471 · Cited by 237
Self-citationVIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS
Lindenmann, J., & Klein, P. A. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.1.93 · Cited by 232
Wang, M., Bronte, V, Chen, P. W., Gritz, L., Panicali, D., Rosenberg, S. A., & Restifo, N. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4685 · Cited by 230
T cell priming versus T cell tolerance induced by synthetic peptides.
Aichele, P., Brduscha-Riem, K., Zinkernagel, R. M., Hengartner, H., & Pircher, H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.261 · Cited by 229
In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter
Huang, A. Y. C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · Immunity · doi:10.1016/s1074-7613(00)80248-4 · Cited by 224
Self-citationGenes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes
Pel, A. V., Van Der Bruggen, P., Coulie, P. G., Brichard, V. G., Lethéa, B., Van Den Eynde, B., Uyttenhove, C., Renauld, J., & Boon, T. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00084.x · Cited by 218
Human tumor antigens recognized by T cells
Robbins, P. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80078-1 · Cited by 210
Toes, R. E., Blom, R. J., Offringa, R., Kast, W. M., & Melief, C. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3911 · Cited by 208
Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes
Vierboom, M. P. M., Nijman, H. W., Offringa, R., Voort, E. I. H. V. D., Hall, T. V., Broek, L. V. D., Fleuren, G. J., Kenemans, P., Kast, W. M., & Melief, C. J. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.695 · Cited by 206
Induction of anti-self-immunity to cure cancer
Nanda, N. K., & Sercarz, E. E. (1995) · Cell · doi:10.1016/0092-8674(95)90047-0 · Cited by 196
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Irvine, K. R., Chamberlain, R. S., Shulman, E., Surman, D. R., Rosenberg, S. A., & Restifo, N. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1595 · Cited by 155
Oncogenic proteins as tumor antigens
Disis, M. L. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80079-3 · Cited by 154
Juillard, V., Villefroy, P., Godfrin, D., Pavirani, A., Venet, A., & Guillet, J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251239 · Cited by 144
Urban, J. L., Burton, R. C., Holland, J. M., Kripke, M. L., & Schreiber, H. W. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.2.557 · Cited by 135
Chen, P. W., Wang, M., Bronte, V., Zhai, Y., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.224 · Cited by 134
Ikonomidis, G., Paterson, Y. Y. W., Kos, F. J., & Portnoy, D. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2209 · Cited by 132
Tumor immunotherapy: the tumor cell as an antigen-presenting cell
Ostrand‐Rosenberg, S. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90075-2 · Cited by 130
Efficiency of MHC class I antigen processing: A quantitative analysis
Villanueva, M. S., Fischer, P. R., Feen, K., & Pamer, E. G. (1994) · Immunity · doi:10.1016/1074-7613(94)90090-6 · Cited by 118
Schafer, R., Portnoy, D. A., Brassell, S., & Paterson, Y. Y. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.53 · Cited by 117
Bronte, V., Tsung, K., Rao, J. B., Chen, P. W., Wang, M., Rosenberg, S. A., & Restifo, N. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5282 · Cited by 115
Restifo, N. P., Esquivel-Guadarrama, F. R., Asher, A. L., Stötter, H., Barth, R. J., Bennink, J. R., Mulé, J. J., Yewdell, J. W., & Rosenberg, S. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1453 · Cited by 113
The endoplasmic reticulum‐resident stress protein gp96 binds peptides translocated by TAP
Lammert, E., Arnold, D., Nijenhuis, M., Momburg, F., Hämmerling, G. J., Brunner, J., Stevanović, S., Rammensee, H., & Schild, H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270418 · Cited by 110
Multiple tumour-specific antigens expressed on a single tumour cell
Wortzel, R. D., Philipps, C., & Schreiber, H. W. (1983) · Nature · doi:10.1038/304165a0 · Cited by 108
Tumour prevention and rejection with recombinant vaccinia
Lathe, R., Kiény, M. P., GERLINGER, P., Clertant, P., Guizani, I., Cuzin, F., & Chambon, P. (1987) · Nature · doi:10.1038/326878a0 · Cited by 103
Bernards, R., Destree, A. T., McKenzie, S. J., Gordon, E., Weinberg, R. A., & Panicali, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6854 · Cited by 98
Innate immunity to a facultative intracellular bacterial pathogen
Portnoy, D. A. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90118-x · Cited by 87
Identification of the Genes Encoding Cancer Antigens: Implications for Cancer Immunotherapy
Rosenberg, S. A., Kawakami, Y., Robbins, P. F., & Wang, R. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60874-x · Cited by 74
Extrathymic Acquisition of Tolerance by T LymphocytesPreprint
Miller, J. F. A. P., Morahan, G., & Allison, J. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.094 · Cited by 38
Cited by
Shimizu, J., Yamazaki, S., & Sakaguchi, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5211 · Cited by 1,491
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Self-citationThurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226
Dendritic cells as therapeutic vaccines against cancer
Banchereau, J., & Palucka, A. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1592 · Cited by 1,204
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Self-citation
Metadata
- Authors
- Pardoll, D. M.
- Venue
- Nature Medicine
- Published
- 1998-05
- Volume
- 4
- Issue
- S5
- Pages
- 525-531
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4211174180
- Cited by
- 428
- References
- 100
- FWCI
- 18.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.